ConvaTec welcomes Heather Mason to its Board as Non-Executive Director

– UK, Reading –  ConvaTec Group Plc (LON: CTEC) today announced the appointment of Heather Mason to its Board as a Non-Executive Director effective from 1 July 2020.

“I am very pleased to welcome Heather to our Board. She has deep healthcare knowledge and brings very relevant international, commercial and operational experience. In particular, as we increase our focus on innovation to help drive our transformation, her track record of overseeing the development of commercially viable new product pipelines and brand building will be invaluable.” said John McAdam, Board Chairman.

About Heather Mason

Heather has significant international healthcare experience leading fully integrated global businesses. Previously she spent 27 years with Abbott Laboratories where she held a number of global senior operational and strategic leadership roles, including Senior Vice President of Abbott Diabetes Care and most recently Executive Vice President of Abbot Nutrition. She retired from Abbot Laboratories in 2017.

Heather is currently a Non-Executive Director of Assertio Therapeutics, Inc., the Nasdaq listed speciality pharmaceutical company focused on providing responsible solutions to advance patient care in the areas of neurology, orphan and speciality medicines. She is also Co-Chair of the University of Michigan’s College of Engineering Innovation Committee and a member of its Leadership Advisory Board.

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has established market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. ConvaTec’s products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care.

For more information:

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.